Kurt Rasmussen

Kurt Rasmussen

Company: The National Institute on Drug Abuse (NIDA)

Job title: Director, Division of Therapeutics & Medical Consequences


Dr. Rasmussen is an internationally recognized neuroscientist, who specializes in basic addiction research and drug development.  Dr. Rasmussen has extensive knowledge of neuropsychiatric and neurological therapeutics and is known for his expertise in pharmaceutical discovery research from hypothesis generation to clinical candidate evaluation.  As Director of the Division of Therapeutics and Medical Consequences, Dr. Rasmussen directs NIDA’s Medications Development Program, evaluating the safety and efficacy of pharmacotherapies, behavioral therapies, and devices to treat substance use disorders through peer reviewed grants, contracts, and interagency agreements.  Previous experience includes 28 years at Eli Lilly. He joined NIDA in April 2018.


Live Q&A 6:50 pm

Read more

day: Day One

Addressing the Opioid Crisis & Driving a Change 5:35 pm

How can the pharmaceutical industry tackle the opioid crisis? What are the current limitations and hesitations?  Exploring biotech activity for the treatment of addiction  How NIDA can be a catalyst for finding treatments for addictionRead more

day: Day One

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.